Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-24-005529
Filing Date
2024-11-12
Accepted
2024-11-12 11:53:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 LAURION CAPITAL MANAGEMENT LP pyxsa1_111224.htm SC 13G/A 44601
  Complete submission text file 0001085146-24-005529.txt   46157
Mailing Address 360 MADISON AVENUE SUITE 2000 NEW YORK NY 10017
Business Address 360 MADISON AVENUE SUITE 2000 NEW YORK NY 10017 212-938-6325
Laurion Capital Management LP (Filed by) CIK: 0001390202 (see all company filings)

EIN.: 562504425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Subject) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92951 | Film No.: 241445821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)